The boutique healthcare investment conference in Chicago is scheduled for May 21-22. Space is limited so register today!

The post Healthcare Investment Trends Take Center Stage at MedCity INVEST appeared first on MedCity News.

Torl BioTherapeutics’ $158 million Series B-2 financing will finance clinical testing of its pipeline of antibody drug conjugates in development for various types of cancer. Neuroscience and immunology are among the therapeutic areas represented in our roundup of other recent biotech financings.

The post Another ADC Developer Lands a Mega Round of Financing for Cancer Clinical Trials appeared first on MedCity News.

These health tech companies focused on the consumer and self-insured employer market will take part in the MedCity INVEST Pitch Perfect contest May 21-22 in Chicago. Register today!

The post 6 Women’s Health Startups You Should Get to Know appeared first on MedCity News.

Seaport Therapeutics’ drug candidates are delivered through the lymphatic system, an approach that could overcome some limitations of neuropsychiatric medicines, including products from Sage Therapeutics. The startup stems from the research of PureTech Health.

The post PureTech Startup Gets $100M to Try For Success Where Sage & Others Fall Short in Depression appeared first on MedCity News.

The MedCity INVEST conference is scheduled for May 21-22 at the Ritz Carlton hotel in Chicago. In addition to panel discussions around some of the hottest topics in healthcare transformation, there is also a startup pitch contest, a presentation on government funding for startups and networking opportunities.

The post Boutique Healthcare Investment Event in Chicago Highlights AI, Government Funding, Value-Based Care. Register Today! appeared first on MedCity News.

The conference will be held at the Ritz Carlton hotel in Chicago May 21-22. Space is limited., so secure your spot today to attend!

The post Time is Running Out to Register for Boutique Healthcare Conference MedCity INVEST appeared first on MedCity News.

David Kereiakes, managing partner with Windham Venture Partners, shared his perspective of the health tech sector and investment trends he’s seeing.

The post MedCity INVEST Pitch Perfect Judge Shares Healthcare Investment Perspective appeared first on MedCity News.

Mirador Therapeutics applies machine learning to human data to discover new immunology and inflammation drugs. The startup’s management includes several from the executive team of Prometheus Biosciences, an immunology biotech bought by Merck last year.

The post Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs appeared first on MedCity News.

The premier boutique healthcare investment conference is scheduled for May 21-22 at the Ritz Carlton hotel in Chicago

The post Come to MedCity INVEST, Where You Could Meet Your Startup’s First Institutional Investor or a Future Portfolio Company! appeared first on MedCity News.

MedCity INVEST 2024, scheduled for May 21-22 at the Ritz Carlton hotel in Chicago, is the ideal event to discuss healthcare funding with investors looking for investment opportunities. 

The post Don’t Miss the Best Boutique Healthcare Investment Conference — Register for MedCity INVEST Today! appeared first on MedCity News.

The conference, scheduled for May 21-22 at the Ritz Carlton hotel in Chicago, brings together healthcare investors, startups, and innovative-minded executives. Register today!

The post Network With Healthcare Investors at MedCity INVEST 2024! appeared first on MedCity News.

The conference, scheduled for May 21-22 at the Ritz Carlton in Chicago, is the premier boutique healthcare investment event in the U.S.

The post Register for MedCity INVEST in Chicago Where Investors and Healthcare Startups Connect appeared first on MedCity News.

The conference is the premier boutique healthcare investment event in the U.S.

The post Network With More Than 50 Healthcare VC firms at MedCity INVEST 2024! appeared first on MedCity News.

General Catalyst just announced its plans to acquire Summa Health, an Ohio-based health system. Leaders from across the healthcare industry aren’t sure how the deal will play out, given the novel nature of the deal and the involvement of one of the country’s most prominent VC firms.

The post Is General Catalyst Buying Summa Health a Good Idea? Only Time Will Tell appeared first on MedCity News.

There are a lack of women at venture capital firms. This makes it difficult for women’s health startups focused on stigmatized conditions to get funding when pitching to those who don’t always have a good understanding, startups say.

The post ‘I’ll Ask My Wife About This’: The Silly Things Women’s Health Entrepreneurs Hear From Male VCs appeared first on MedCity News.

Available atopic dermatitis drugs work by blocking inflammation, but Triveni Bio is developing an antibody that addresses a root cause of the chronic condition. The startup is out of stealth to advance its lead program and a pipeline of other inflammation and immunology drugs.

The post Biotech Startup Triveni Unveils $92M to Address Barrier to Treating Inflammation appeared first on MedCity News.

Investment trends will be a big theme at the HLTH event at the Las Vegas Convention Center October 8-11. In the runup to the conference, investors from Bessemer Venture Partners, Cleveland Clinic Innovations, Third Culture Capital and Intuitive Ventures offered their takes on 2023 investments.

The post Investors Share Perspectives on 2023 Deals and Offer a Look at Emerging Areas of Interest appeared first on MedCity News.

7wireVentures launched its largest fund to date on Tuesday — the closing of the $217 million digital health fund brings the Chicago-based firm’s assets under management to more than $500 million. Two-thirds of the new fund’s capital will be allocated to 7wireVentures’ existing portfolio companies for follow-up investments, and the remaining third will go toward Series B and Series C funding round for companies in which the firm hasn’t yet invested.

The post 7wireVentures Launches $217M Digital Health Fund appeared first on MedCity News.

Healthcare IT companies raised $1 billion in venture capital in Q2 — down slightly from the $1.3 billion raised in Q1 but up significantly from the $451.3 million raised in Q4 2022. Unsurprisingly, a lot of these investments were made in companies offering generative AI products. Another key trend was increasing cash flow to remote patient monitoring startups, likely caused by expanded reimbursement for these services.

The post Generative AI, RPM Were Among the Biggest Trends In Health IT Fundraising During Q2 appeared first on MedCity News.

Avalon BioVentures unveiled new portfolio company Arialys Therapeutics. The startup’s lead program, an antibody from Astellas Pharma, is a potential treatment for anti-NMDA receptor encephalitis (ANRE), a rare autoimmune inflammatory disorder.

The post Neuro Startup Arialys Raises $58M for Privilege of Tackling Brain Inflammation appeared first on MedCity News.

Startup Star Therapeutics will use the Series B funding to support clinical development of a drug candidate for von Willebrand disease, a bleeding disorder. The capital will also support the formation of new biotech subsidiaries developing antibodies with therapeutic applications in hematology and immunology.

The post Star Therapeutics Lands $90M to Expand Its Drug Discovery Universe appeared first on MedCity News.

Intarcia Therapeutics’ GLP-1 agonist product candidate for type 2 diabetes now belongs to i2o Therapeutics, which will make the treatment’s case for approval at an upcoming FDA advisory committee meeting. The startup’s $46 million Series A financing is one of several recently announced funding rounds.

The post Twice Rejected Diabetes Drug/Device Product Gets New Chance at Startup i2o appeared first on MedCity News.

Medtech funding reached its low point in the first quarter but will slowly pick back up over the rest of 2023, according to a new Pitchbook report. It noted that this year’s medtech funding total will not come close to the $19.7 billion the sector raised in 2021, and it might even come in below last year’s funding total of $13.5 billion.

The post Medtech Funding Expected to Pick Up In 2023 After Q1’s Low Point appeared first on MedCity News.

Septerna Therapeutics’ Series B financing will support plans to reach the clinic with a pill for a rare disease whose only approved therapy is a Takeda Pharmaceutical drug that’s leaving the market. Potential rival therapies are all injectables.

The post RA Capital Leads $150M Financing for Septerna and Lead Drug With Oral Edge in Rare Hormone Disease appeared first on MedCity News.

The digital health sector has entered a new era when it comes to funding, and startups in this space must quickly adjust to an investment landscape that is characterized by lower check sizes, fewer deals and smaller cohort of investors. If things continue at the pace the sector has maintained throughout the first half of the year, 2023 will mark the field’s lowest yearly fundraising total since 2019, according to a new report.

The post Digital Health’s H1 Funding Landscape: Slimmer Checks, Fewer Deals & a Smaller Investor Pool appeared first on MedCity News.

Two VCs from Merck Global Health Innovation Fund recently offered fundraising advice for digital health companies. They told these firms to expect slower funding timelines, urged them not to be afraid of down or flat rounds, and advised them to spend time nailing down the specifics of their growth narrative.

The post ‘Hope Is Not a Business Model’: Digital Health Fundraising Advice from 2 VCs appeared first on MedCity News.

Healthcare IT companies experienced a bounceback in venture capital deal activity during Q1 of 2023. Rebecca Springer, PitchBook ’s lead healthcare analyst, said she is optimistic that healthcare IT startups will be able to keep this momentum going, especially those focused on staffing and value-based care enablement.

The post Why One Analyst Is Encouraged by Healthcare IT’s Fundraising Rebound appeared first on MedCity News.

Global funding for digital health companies finally stabilized in Q1 of this year. The sector raised $3.4 billion — this marks the first time the digital health world didn’t experience a quarter-over-quarter funding decline since Q4 of 2021. By holding steady, digital health startups defied the dwindling fundraising totals seen across the broader venture capital landscape, where funding dropped by 13% quarter-over-quarter.

The post Digital Health Funding Steadied in Q1 After a Year of Decline appeared first on MedCity News.

Ask the Investor sessions at MedCity INVEST at the Ritz Carlton in Chicago May 22-24 offer opportunities for startups to talk with investors in intimate settings. Spots are limited so register today!

The post MedCity INVEST Ask the Investor Spotlight: Rachel Kern of First Trust Capital Partners appeared first on MedCity News.

While the digital health sector might feel a little cramped in some areas, there are wide open spaces in others — and investors are ready to funnel money into companies looking to innovate these lesser-discussed aspects of care delivery and healthcare technology. Some of these areas include Medicaid, generative AI and patient-to-patient support.

The post In Which Areas of Healthcare Do Investors Want More Startup Activity? appeared first on MedCity News.